NORETHIN 1/50M-21 Drug Patent Profile
✉ Email this page to a colleague
When do Norethin 1/50m-21 patents expire, and what generic alternatives are available?
Norethin 1/50m-21 is a drug marketed by Heritage Pharma and is included in one NDA.
The generic ingredient in NORETHIN 1/50M-21 is mestranol; norethindrone. There is one drug master file entry for this compound. Additional details are available on the mestranol; norethindrone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NORETHIN 1/50M-21?
- What are the global sales for NORETHIN 1/50M-21?
- What is Average Wholesale Price for NORETHIN 1/50M-21?
Summary for NORETHIN 1/50M-21
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Patent Applications: | 89 |
| DailyMed Link: | NORETHIN 1/50M-21 at DailyMed |
US Patents and Regulatory Information for NORETHIN 1/50M-21
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heritage Pharma | NORETHIN 1/50M-21 | mestranol; norethindrone | TABLET;ORAL-21 | 071539-001 | Apr 12, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
